[Cancer burden in the Jinchang cohort]

Zhonghua Liu Xing Bing Xue Za Zhi. 2016 Mar;37(3):306-10. doi: 10.3760/cma.j.issn.0254-6450.2016.03.002.
[Article in Chinese]

Abstract

Objective: To understand the disease burden caused by cancers in Jinchang cohort, and develop effective strategies for cancer prevention and control in this population.

Methods: The cancer mortality data from 2001 to 2013 and the medical records for cancer patients from 2001 to 2010 in Jinchang cohort were collected. The disease burden caused by cancer was analyzed by using mortality rate, potential years of life lost (PYLL), working PYLL (WPYLL), and direct economic burden.

Results: During 2001-2013, in Jinchang cohort, the five leading cancers ranked by mortality rate were lung cancer (78.06/100,000), gastric cancer (38.03/100,000), liver cancer (37.23/100,000), esophageal cancer (19.06/100,000), and colorectal cancer (9.53/100,000). The five leading cancers in terms of PYLL (person-years) and WPYLL (person-years) were lung cancer (3480.33, 1161.00), liver cancer (2809.03, 1475.00), gastric cancer (2120.54, 844.00), esophageal cancer (949.61, 315.00), and colorectal cancer (539.90, 246.00). From 2001 to 2010, the five leading cancers in term of average daily cost of hospitalization were gastric cancer (8,102.23 Yuan), esophageal cancer (7135.79 Yuan), colorectal cancer (7064.38 Yuan), breast cancer (6723.53 Yuan), and lung cancer (6309.39 Yuan).

Conclusions: The cancers common causing higher disease burden in Jinchang cohort were lung cancer, gastric cancer, liver cancer, esophageal cancer and colorectal cancer. The lung cancer disease burden was the highest.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / economics
  • Breast Neoplasms / mortality
  • China / epidemiology
  • Cohort Studies
  • Colorectal Neoplasms / economics
  • Colorectal Neoplasms / mortality
  • Cost of Illness*
  • Esophageal Neoplasms / economics
  • Esophageal Neoplasms / mortality
  • Female
  • Hospitalization / economics
  • Humans
  • Liver Neoplasms / economics
  • Liver Neoplasms / mortality
  • Lung Neoplasms / economics
  • Lung Neoplasms / mortality
  • Male
  • Neoplasms / economics*
  • Neoplasms / mortality*
  • Stomach Neoplasms / economics
  • Stomach Neoplasms / mortality